Literature DB >> 21093830

Invasive ductal carcinoma arising in phyllodes tumor with isolated tumor cells in sentinel lymph node.

Ying-Ju Kuo1, Donald Ming-Tak Ho, Yi-Fang Tsai, Chih-Yi Hsu.   

Abstract

Phyllodes tumor (PT) consists of stroma of variable grading and benign ductal epithelium. Although exceptional, carcinomas that arise from the epithelium in PTs do exist, and seem to behave less aggressively than the usually encountered breast carcinoma. To the best of our knowledge, among the invasive carcinomas that have arisen in PTs, only 1 has been proved to have metastatic carcinoma in the lymph nodes. Here, we describe the youngest woman to have invasive ductal carcinoma that arose in a borderline PT, with isolated carcinoma cells in the sentinel lymph node. Whether such a combined lesion carries a more indolent course is also discussed.
Copyright © 2010 Elsevier. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21093830     DOI: 10.1016/S1726-4901(10)70131-3

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  4 in total

Review 1.  Ductal carcinoma in-situ arising within benign phyllodes tumours.

Authors:  S-A Lui; H B Oh; S Wang; C W Chan
Journal:  Ann R Coll Surg Engl       Date:  2018-02-27       Impact factor: 1.891

2.  Invasive ductal carcinoma within borderline phyllodes tumor with lymph node metastases: A case report and review of the literature.

Authors:  D I Wu; Haipeng Zhang; Liang Guo; X U Yan; Zhimin Fan
Journal:  Oncol Lett       Date:  2016-02-17       Impact factor: 2.967

3.  Malignant Epithelial Transformation in Phyllodes Tumor: A Population-Based Case Series.

Authors:  Ralph L Widya; Myra F Rodrigues; Pauline T Truong; Peter H Watson; Lorna M Weir; Margaret A Knowling; Elaine S Wai
Journal:  Cureus       Date:  2017-11-03

4.  Ductal carcinoma in situ in a benign phyllodes tumor of breast: A rare presentation.

Authors:  Prithwijit Ghosh; Kaushik Saha
Journal:  J Nat Sci Biol Med       Date:  2014-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.